Tianda Pharmaceuticals Limited provided consolidated earnings guidance for the financial year ended 31 March 2015. For the period, the company expected to record consolidated loss as compared with the consolidated profit recorded in the financial year ended 31 March 2014. Due to Yunnan Meng Sheng Pharmaceutical Co., Limited, a subsidiary of the company, took longer time than expected for its construction works for expansion of the original production line and the New GMP authentication that the New GMP Version certificate was obtained in late January 2015.

As a consequence, its sales and earnings were affected and in turn led to the expected Group's consolidated loss.